Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy and Nuclear Resonance Vibrational Spectroscopy Comparative Study
Total Page:16
File Type:pdf, Size:1020Kb
Journal of Applied Biotechnology & Bioengineering Image Article Open Access Atomic force microscopy based infrared (AFM–IR) spectroscopy and nuclear resonance vibrational spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time Image introduction Volume 5 Issue 3 - 2018 In the current study, we have experimentally and comparatively investigated and compared malignant human cancer cells and tissues Alireza Heidari before and after irradiating of synchrotron radiation using Atomic Faculty of Chemistry, California South University, USA Force Microscopy Based Infrared (AFM–IR) Spectroscopy and Nuclear Resonance Vibrational Spectroscopy. It is clear that malignant Correspondence: Alireza Heidari, Faculty of Chemistry, human cancer cells and tissues have gradually transformed to benign California South University, 14731 Comet St. Irvine, CA 92604, USA, Email [email protected], Alireza. human cancer cells and tissues under synchrotron radiation with the [email protected] passage of time (Figures 1 & 2).1–145 It should be noted that malignant human cancer cells and tissues were exposed under white synchrotron Received: February 21, 2018 | Published: May 14, 2018 radiation for 30 days. Furthermore, there is a shift of the spectrum in all of spectra after irradiating of synchrotron radiation that it is because of the malignant human cancer cells and tissues shrink post white synchrotron irradiation with the passage of time. In addition, all of the figures are related to the same human cancer cells and tissues. Moreover, in all of the figures y–axis shows intensity and also x–axis shows energy (keV) (Figures 1 & 2).101–145 A A B Figure 2 Nuclear resonance vibrational spectroscopy analysis of malignant human cancer cells and tissues (A) before and (B) after irradiating of synchrotron radiation in transformation process to benign human cancer cells B and tissues with the passage of time.1–145 It can be concluded that malignant human cancer cells and tissues Figure 1 Atomic force microscopy based infrared (AFM–IR) Spectroscopy have gradually transformed to benign human cancer cells and tissues analysis of malignant human cancer cells and tissues (A) before and (B) after under synchrotron radiation with the passage of time (Figures 1 & irradiating of synchrotron radiation in transformation process to benign 2).1–145 It should be noted that malignant human cancer cells and human cancer cells and tissues with the passage of time.1–145 tissues were exposed under white synchrotron radiation for 30 days. Submit Manuscript | http://medcraveonline.com J Appl Biotechnol Bioeng. 2018;5(3):138‒144. 138 © 2018 Heidari. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially. Atomic force microscopy based infrared (AFM–IR) spectroscopy and nuclear resonance vibrational Copyright: spectroscopy comparative study on malignant and benign human cancer cells and tissues under ©2018 Heidari 139 synchrotron radiation with the passage of time Furthermore, there is a shift of the spectrum in all of spectra after oxide (CdO) nanoparticles on dna of cancer cells: a photodynamic therapy irradiating of synchrotron radiation that it is because of the malignant study. Arch Cancer Res. 2016;4:1. human cancer cells and tissues shrink post white synchrotron 14. Heidari A. Biospectroscopic study on multi–component reactions (mcrs) irradiation with the passage of time. In addition, all of the figures are in two a–type and b–type conformations of nucleic acids to determine related to the same human cancer cells and tissues. Moreover, in all of ligand binding modes, binding constant and stability of nucleic acids in the figures y–axis shows intensity and also x–axis shows energy (keV) cadmium oxide (CdO) nanoparticles–nucleic acids complexes as anti– (Figures 1 & 2).101–145 cancer drugs. Arch Cancer Res. 2016;4:2. 15. Heidari A. Simulation of temperature distribution of DNA/RNA of human Acknowledgements cancer cells using time–dependent bio–heat equation and Nd: YAG lasers. None. Arch Cancer Res. 2016;4:2. 16. Heidari A. Quantitative structure–activity relationship (QSAR) Conflict of interest approximation for cadmium oxide (CdO) and rhodium (III) oxide (Rh2O3) nanoparticles as anti–cancer drugs for the catalytic formation of proviral The authors declare that there is no conflict of interest. DNA from viral RNA using multiple linear and non–linear correlation approach. Ann Clin Lab Res. 2016;4:1. References 17. Heidari A. Biomedical study of cancer cells DNA therapy using laser 1. Heidari A, Brown C. Study of composition and morphology of cadmium irradiations at presence of intelligent nanoparticles. J Biomedical Sci. oxide (CdO) nanoparticles for eliminating cancer cells. J Nanomed Res. 2016;5:2. 2015;2(5):1‒20. 18. Alireza Heidari. Measurement the amount of vitamin D2 (Ergocalciferol), 2. Heidari A, Brown C. Study of surface morphological, phytochemical and vitamin D3 (Cholecalciferol) and absorbable calcium (Ca2+), iron 2+ 2+ 4– 2+ structural characteristics of Rhodium (III) Oxide (Rh2O3) nanoparticles. (II) (Fe ), magnesium (Mg ), phosphate (PO ) and zinc (Zn ) in International Journal of Pharmacology, Phytochemistry and apricot using high–performance liquid chromatography (HPLC) and Ethnomedicine. 2015;1:15–19. spectroscopic techniques. J Biom Biostat. 2016;7:292. 3. Heidari A. An experimental biospectroscopic study on seminal plasma in 19. Heidari A. Spectroscopy and quantum mechanics of the helium dimer determination of semen quality for evaluation of male infertility. Int J Adv (He2+), neon dimer (Ne2+), argon dimer (Ar2+), krypton dimer (Kr2+), Technol. 2016;7(2):1‒2. xenon dimer (Xe2+), radon dimer(Rn2+) and ununoctium dimer (Uuo2+) 4. Heidari A. Extraction and preconcentration of N–Tolyl–Sulfonyl– molecular cations. Chem Sci J. 2016;7:e112. Phosphoramid–Saeure–Dichlorid as an anti–cancer drug from plants: a 20. Heidari A. Human toxicity photodynamic therapy studies on DNA/RNA pharmacognosy study. J Pharmacogn Nat Prod. 2016;2:e103. complexes as a promising new sensitizer for the treatment of malignant 5. Alireza Heidari. A thermodynamic study on hydration and dehydration tumors using bio–spectroscopic techniques. J Drug Metab Toxicol. of DNA and RNA−Amphiphile complexes. J Bioeng Biomed Sci S. 2016;7:e129. 2016:006. 21. Heidari A. Novel and stable modifications of intelligent cadmium oxide 6. Heidari A. Computational studies on molecular structures and carbonyl (CdO) nanoparticles as anti–cancer drug in formation of nucleic acids and ketene groups’ effects of singlet and triplet energies of azidoketene complexes for human cancer cells’ treatment. Biochem Pharmacol (Los O=C=CH–NNN and isocyanatoketene O=C=CH–N=C=O. J Appl Angel). 2016;5:207. Computat Math. 2016;5:e142. 22. Heidari A. A combined computational and QM/MM molecular dynamics 7. Heidari A. Study of irradiations to enhance the induces the dissociation study on boron nitride nanotubes (BNNTs), amorphous boron nitride of hydrogen bonds between peptide chains and transition from helix nanotubes (a–BNNTs) and hexagonal boron nitride nanotubes (h–BNNTs) structure to random coil structure using ATR–FTIR, raman and 1HNMR as hydrogen storage. Struct Chem Crystallogr Commun. 2016;2:1. spectroscopies. J Biomol Res Ther. 2016;5:e146. 23. Heidari A. Pharmaceutical and analytical chemistry study of cadmium 8. Heidari A. Future Prospects of Point Fluorescence Spectroscopy, oxide (CdO) nanoparticles synthesis methods and properties as anti– Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic cancer drug and its effect on human cancer cells. Pharm Anal Chem Open Therapy (PDT) for Cancer Cells. J Bioanal Biomed. 2016;8:e135. Access. 2016;2:113. 9. Alireza Heidari. A bio–spectroscopic study of DNA density and color role 24. Heidari A. A chemotherapeutic and biospectroscopic investigation of as determining factor for absorbed irradiation in cancer cells. Adv Cancer the interaction of double–standard DNA/RNA–binding molecules with cadmium oxide (CdO) and rhodium (III) oxide (Rh O ) nanoparticles Prev. 2016;1:e102. 2 3 as anti–cancer drugs for cancer cells’ treatment. Chemo Open Access. 10. Heidari A. Manufacturing process of solar cells using cadmium oxide 2016;5:e129. (CdO) and rhodium (III) oxide (Rh2O3) Nanoparticles. J Biotechnol Biomater. 2016;6:e125. 25. Heidari A. Pharmacokinetics and experimental therapeutic study of DNA and other biomolecules using lasers: advantages and applications. J 11. Heidari A. A Novel Experimental and Computational Approach to Pharmacokinet Exp Ther. 2016;1:e005. Photobiosimulation of Telomeric DNA/RNA: A Biospectroscopic and Photobiological Study. J Res Development. 2016;4:144. 26. Heidari A. Determination of Ratio and Stability Constant of DNA/ RNA in Human Cancer Cells and Cadmium Oxide (CdO) Nanoparticles 12. Heidari A. Biochemical and pharmacodynamical study of microporous Complexes Using Analytical Electrochemical and Spectroscopic molecularly imprinted polymer selective for vancomycin, teicoplanin, Techniques. Insights Anal Electrochem. 2016;2:1. oritavancin, telavancin and dalbavancin binding. Biochem Physiol. 2016;5:e146. 27. Heidari A. Discriminate between antibacterial and non–antibacterial drugs artificial neutral networks of a multilayer perceptron (MLP) type 13. Heidari A. Anti–cancer effect of UV irradiation at presence of